Donepezil SR 23 mg Tablets BE study [Study Per­for­mance]

posted by drgunasakaran1  – 2010-07-17 09:23 (5823 d 23:05 ago) – Posting: # 5647
Views: 13,425

Dear Mr.Madhav,

FDA recommends to conduct Single dose, two way cross over (both Fasting and Fed studies) in males and non-pregnant females general population for Donepezil. Hence, you can conduct the bioequivalence study in healthy volunteers not in patients with Alzheimer's Disease.

Regards,
Dr.S.Gunasakaran, MD

Dr Gunasakaran Sambandan MD
Disclaimer: The replies/posts are my personal opinions, and they do not represent my company's views on the same. LinkedIn

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
380 visitors (0 registered, 380 guests [including 17 identified bots]).
Forum time: 08:28 CEST (Europe/Vienna)

Don’t compromise yourself.
You are all you’ve got.    Janis Joplin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5